Home Categories (3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol
(3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol
SDS-US
LN-081934

(3R,4S,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol , 0.95 , 1620758-34-0

CAS NO.：1620758-34-0

Empirical Formula: C23H29ClO8

Molecular Weight: 468.92

MDL number: MFCD33551693

Update time: 2023-04-23

PRODUCT Properties

Boiling point: 770.5±60.0 °C(Predicted)
Density  1.435±0.06 g/cm3(Predicted)
pka 13.25±0.20(Predicted)

Description and Uses

(1R)-1,5,-Dihydroxyempagliflozin is an impurity of Empagliflozin (E521510) which is a novel, potent and selective SGLT-2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats.

RELATED PRODUCTS

Empagliflozin (BI 10773)
Empagliflozin (BI 10773)
864070-44-0
Empagliflozin Dimer Impurity
Empagliflozin Dimer Impurity
Butanoic acid, 4-chloro-3-hydroxy-, (3S)-
Butanoic acid, 4-chloro-3-hydroxy-, (3S)-
106941-19-9
EMpagliflozin iMpurity 14
EMpagliflozin iMpurity 14
2137418-13-2
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol
915095-96-4